Sinew Pharma Overview
- Year Founded
-
2014
- Status
-
Public
- Employees
-
57
- Stock Symbol
-
6634
- Share Price
-
$1.79
- (As of Monday Closing)
Sinew Pharma General Information
Description
Sinew Pharma Inc is a Taiwan-based biopharmaceutical company. The company is mainly engaged in the research and development of new drugs for the treatment of liver diseases and pain relief. Its drug candidates includes SNP-610, SNP-630, SNP-810, SNP-820, SNP-830 and SNP-840.
Contact Information
Website
www.sinewpharma.comCorporate Office
- Room C516, Building C
- No. 99, Lane 130, Section 1 Yanjiuyuan Road, Nangang District
- Taipei, 115-71
- Taiwan
Corporate Office
- Room C516, Building C
- No. 99, Lane 130, Section 1 Yanjiuyuan Road, Nangang District
- Taipei, 115-71
- Taiwan
Sinew Pharma Stock Performance
As of 16-Nov-2026, Sinew Pharma’s stock price is $1.79. Its current market cap is $128M with 71.3M shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.79 | $1.83 | $0.91 - $2.69 | $128M | 71.3M | 98.8K | -$0.05 |
Sinew Pharma Financials Summary
As of 30-Jun-2026, Sinew Pharma has a trailing 12-month revenue of $1.51K.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 129,978 | 54,544 | 66,132 | 111,636 |
| Revenue | 2 | 2 | 0 | |
| EBITDA | (3,909) | (3,845) | (4,248) | (5,047) |
| Net Income | (3,812) | (3,967) | (4,686) | (5,487) |
| Total Assets | 33,463 | 36,056 | 37,287 | 44,369 |
| Total Debt | 385 | 486 | 86 | 302 |
Sinew Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sinew Pharma Patents
Sinew Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2021513548-A | Methods and compositions for preventing, reducing or eradicating the toxicity caused by acetaminophen (apap) | Pending | 14-Feb-2018 | ||
| AU-2019220062-A1 | Methods and compositions for preventing, reducing or eradicating toxicity caused by acetaminophen (apap) | Active | 14-Feb-2018 | ||
| AU-2019220062-B2 | Methods and compositions for preventing, reducing or eradicating toxicity caused by acetaminophen (apap) | Active | 14-Feb-2018 | ||
| CA-3090029-A1 | Methods and compositions for preventing, reducing or eradicating toxicity caused by acetaminophen (apap) | Pending | 14-Feb-2018 | ||
| EP-3752140-A1 | Methods and compositions for preventing, reducing or eradicating toxicity caused by acetaminophen (apap) | Pending | 14-Feb-2018 | A61K31/78 |
Sinew Pharma Signals
Sinew Pharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Sinew Pharma FAQs
-
When was Sinew Pharma founded?
Sinew Pharma was founded in 2014.
-
Where is Sinew Pharma headquartered?
Sinew Pharma is headquartered in Taipei, Taiwan.
-
What is the size of Sinew Pharma?
Sinew Pharma has 57 total employees.
-
What industry is Sinew Pharma in?
Sinew Pharma’s primary industry is Pharmaceuticals.
-
Is Sinew Pharma a private or public company?
Sinew Pharma is a Public company.
-
What is Sinew Pharma’s stock symbol?
The ticker symbol for Sinew Pharma is 6634.
-
What is the current stock price of Sinew Pharma?
As of 16-Nov-2026 the stock price of Sinew Pharma is $1.79.
-
What is the current market cap of Sinew Pharma?
The current market capitalization of Sinew Pharma is $128M.
-
What is Sinew Pharma’s current revenue?
The trailing twelve month revenue for Sinew Pharma is $1.51K.
-
What is Sinew Pharma’s annual earnings per share (EPS)?
Sinew Pharma’s EPS for 12 months was -$0.05.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process